Printer Friendly

Baby lung tester.

Midland-based medical products group Ferraris has made a major medical breakthrough with the approval for use of a revolutionary baby lung testing device.

It has announced the launch of its Collins Medical division's Infant Pulmonary Laboratory, also known as a Medicrib, the world's first clinically useful infant pulmonary system, following approval from the FDA and CE for sale in the United States and Europe.

At the launch, at the ATS Conference, in Atlanta, Georgia, the company unveiled the features of the product, whose technology is patented.

The IPL attracted considerable interest from customers and the first pounds 67,000 order from a major US children's hospital customer has already been taken.

The IPL is the world's first product to employ a variety of diagnostic methods to enable the accurate measurement of lung volume and function. Developed with researchers at The Children's Hospital, Columbus, Ohio, the IPL enables adult type pulmonary function testing in infants to obtain vital clinical evidence for the diagnosis of conditions such as cystic fibrosis. Prior to its development, the accurate analysis of lung volumes in very small infants was virtually impossible.
COPYRIGHT 2002 Birmingham Post & Mail Ltd
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Business
Publication:The Birmingham Post (England)
Date:Jul 1, 2002
Previous Article:Three-year high of sales for region.
Next Article:CBI after boost from Brown.

Related Articles
One-Third of Severe RDS Cases May Be Preventable.
Babies saved by plastics science.
Healthfocus: The deadly virus that stalks babies.
Steroid danger for premature babies.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters